RTK/RAS pathway was mainly caused by oncogene EGFR (43.8% LGG vs. 25.7% GBM, Fig 5B), while PI3K pathway activation was attributed to tumor suppressor gene PTEN (37.5% LGG vs. 17.1% GBM, Fig 5C). Here, PTEN is linked to glioblastoma.